BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.400
-0.100 (-6.67%)
Jul 14, 2026, 5:24 PM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 39.31 million as of July 14, 2026. Its market cap has decreased by -46.99% in one year.
Market Cap
39.31M
Enterprise Value
26.30M
Revenue
4.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.40
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 39.31M, an increase of 24,015.72%. That is a compound annual growth rate of 32.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 39.31M | -5.89% |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 335.28M |
| Bonus BioGroup | 320.07M |
| Matricelf | 78.32M |
| Clal Biotechnology Industries | 42.51M |
| BioLight Life Sciences | 34.70M |
| Can-Fite BioPharma | 21.36M |
| XTL Biopharmaceuticals | 19.66M |
| Purple Biotech | 18.65M |